Commonwealth Equity Services, LLC Acadia Pharmaceuticals Inc Transaction History

Commonwealth Equity Services, LLC

$63.2 Billion
Q2 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 14,770 shares of ACAD stock, worth $227,310. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,770

Previous 13,992 5.56%

Holding current value

$227,310

Previous $259,000 7.34%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$14.62 - $18.42 $11,374 - $14,330	778 Added 5.56%	14,770 $240,000
Q1 2024 Apr 29, 2024	SELL	$17.79 - $30.86 $4,145 - $7,190	-233 Reduced 1.64%	13,992 $259,000
Q4 2023 Feb 06, 2024	BUY	$20.78 - $31.77 $12,883 - $19,697	620 Added 4.56%	14,225 $445,000
Q3 2023 Oct 23, 2023	SELL	$20.84 - $33.47 $17,714 - $28,449	-850 Reduced 5.88%	13,605 $284,000
Q2 2023 Aug 10, 2023	BUY	$17.8 - $25.65 $4,414 - $6,361	248 Added 1.75%	14,455 $346,000
Q1 2023 May 11, 2023	BUY	$16.32 - $20.92 $4,520 - $5,794	277 Added 1.99%	14,207 $267,000
Q4 2022 Feb 07, 2023	BUY	$14.2 - $18.63 $12,283 - $16,114	865 Added 6.62%	13,930 $221,000
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $6,462 - $8,367	-458 Reduced 3.39%	13,065 $213,000
Q2 2022 Jul 19, 2022	BUY	$13.01 - $27.22 $1,261 - $2,640	97 Added 0.72%	13,523 $190,000
Q1 2022 May 04, 2022	SELL	$20.94 - $27.5 $13,129 - $17,242	-627 Reduced 4.46%	13,426 $325,000
Q4 2021 Jan 31, 2022	SELL	$16.79 - $27.09 $5,356 - $8,641	-319 Reduced 2.22%	14,053 $328,000
Q3 2021 Oct 29, 2021	SELL	$15.78 - $24.77 $18,004 - $28,262	-1,141 Reduced 7.36%	14,372 $238,000
Q2 2021 Aug 11, 2021	SELL	$19.4 - $27.42 $2,910 - $4,113	-150 Reduced 0.96%	15,513 $378,000
Q1 2021 May 04, 2021	SELL	$25.02 - $54.99 $3,377 - $7,423	-135 Reduced 0.85%	15,663 $404,000
Q4 2020 Feb 11, 2021	BUY	$41.04 - $56.79 $16,128 - $22,318	393 Added 2.55%	15,798 $844,000
Q3 2020 Nov 05, 2020	BUY	$36.42 - $57.0 $45,124 - $70,623	1,239 Added 8.75%	15,405 $635,000
Q2 2020 Aug 12, 2020	SELL	$39.26 - $52.73 $22,574 - $30,319	-575 Reduced 3.9%	14,166 $686,000
Q1 2020 May 11, 2020	BUY	$31.65 - $46.87 $5,064 - $7,499	160 Added 1.1%	14,741 $622,000
Q4 2019 Feb 05, 2020	BUY	$36.21 - $51.4 $59,746 - $84,810	1,650 Added 12.76%	14,581 $623,000
Q3 2019 Oct 30, 2019	SELL	$22.22 - $44.01 $18,798 - $37,232	-846 Reduced 6.14%	12,931 $465,000
Q2 2019 Jul 19, 2019	SELL	$23.32 - $28.12 $1,609 - $1,940	-69 Reduced 0.5%	13,777 $368,000
Q1 2019 May 13, 2019	SELL	$16.17 - $27.38 $1,778 - $3,011	-110 Reduced 0.79%	13,846 $371,000
Q4 2018 Feb 11, 2019	SELL	$14.32 - $22.92 $200 - $320	-14 Reduced 0.1%	13,956 $225,000
Q3 2018 Nov 06, 2018	BUY	$13.03 - $21.81 $6,554 - $10,970	503 Added 3.74%	13,970 $290,000
Q2 2018 Jul 31, 2018	SELL	$15.07 - $22.34 $7,881 - $11,683	-523 Reduced 3.74%	13,467 $206,000
Q1 2018 May 14, 2018	BUY	$22.47 - $32.33 $314,355 - $452,296	13,990 New	13,990 $314,000

Others Institutions Holding ACAD

# of Institutions

288

Shares Held

161M

Call Options Held

723K

Put Options Held

257K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.49B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Acadia Pharmaceuticals Inc Transaction History